RA-ILD+ patients showed increased levels of E-selectin, ICAM-1, and ET-1 compared to those with RA-ILD− (p < 0.01 in all the cases, Figure 1A, Table S1 (see Additional File S1)). This evidence concerns the gene SELE and rheumatoid arthritis.